Brca1 Mutation Carrier Active Not Recruiting Phase 2 Trials for Deslorelin (DB11510)

Back to Brca1 Mutation Carrier

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00080756Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseasePrevention